Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Olanzapine has been used for the treatment of schizophrenia and other mental disorders. However, it is associated with serious weight gain and other metabolic side-effects. The antagonistic affinity of olanzapine to muscarinic M3 receptors has been evidenced as one of the main contributors for its w...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.pbb.2020.172878
データ提供：米国国立医学図書館（NLM）
Addressing Olanzapine-Induced Metabolic Side Effects
The field of [pharmacology] is constantly seeking ways to mitigate the adverse effects of medications. This research investigates the potential of [cevimeline], a [muscarinic M3 receptor agonist], in preventing the metabolic side effects associated with [olanzapine] medication. The study uses a [female rat model] to explore the dosage-dependent effects of [cevimeline] on [olanzapine]-induced weight gain and other metabolic disturbances. The findings provide valuable insights into the potential therapeutic applications of [cevimeline] in managing the metabolic side effects of [olanzapine].
Cevimeline Shows Promise in Ameliorating Olanzapine-Induced Metabolic Side Effects
This research demonstrates the potential of [cevimeline] to mitigate the metabolic side effects associated with [olanzapine] medication. The study found that co-treatment with [cevimeline] partially reversed [olanzapine]-induced weight gain, food intake, and other metabolic disturbances in a dosage-dependent manner. This suggests that [cevimeline] may offer a promising therapeutic strategy for managing the metabolic side effects of [olanzapine] medication.
Understanding Drug Interactions and Metabolic Health
This research highlights the importance of understanding drug interactions and their impact on metabolic health. The study demonstrates the potential of [cevimeline] to mitigate the metabolic side effects of [olanzapine] medication. This knowledge can help healthcare providers make informed decisions about medication use, particularly in individuals at risk for [metabolic disturbances].
Dr.Camel's Conclusion
This research investigates the potential of [cevimeline] in preventing the metabolic side effects associated with [olanzapine] medication. The study found that co-treatment with [cevimeline] partially reversed [olanzapine]-induced weight gain, food intake, and other metabolic disturbances in a dosage-dependent manner. This suggests that [cevimeline] may offer a promising therapeutic strategy for managing the metabolic side effects of [olanzapine] medication.
Date :
- Date Completed 2021-01-07
- Date Revised 2021-01-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.